Repurposed spinal cord injury drug reduces DNA damage and inflammation in Alzheimer's models
A drug already tested for initial human safety targets several hallmarks of Alzheimer's disease in experiments.
Read at Sciencedaily →Full coverage · 15 outlets
- Sciencedaily · lead
- Science DailyScientists discover new Alzheimer’s drug that repairs DNA damage and reduces brain inflammation
- Drug Discovery NewsFirst-in-class therapy repairs DNA damage in Alzheimer's model
- Drug Target ReviewKCL-286 targets multiple Alzheimer’s pathways in preclinical study
- BGNESBritish scientists identify promising new drug candidate for Alzheimer’s disease
- Inside Precision MedicineDrug Candidate Shows Early Promise for Treating Alzheimer’s Damage
- Medical News TodayAlzheimer's treatment: DNA repair drug shows promise in mice
- King's College LondonHuman-safe drug repairs DNA in a mouse model of Alzheimer's
- ScienceAlertA Drug Already Proven Safe in Humans Just Reduced Multiple Signs of Alzheimer's in Mice
- Good News NetworkDrug May Repair DNA at Earliest Stages of Alzheimer’s – And it’s Already Passed Safety Trials
- FrontiersNanoparticles: a new frontier in neurodegenerative disease therapy
- NatureRecent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies
- Wiley Online LibraryNeuroprotective Potential of Curcumin in Neurodegenerative Diseases: Clinical Insights Into Cellular and Molecular Signaling Pathways - Islam - 2025 - Journal of Biochemical and Molecular Toxicology
- SciTechDailyResearch Shows Investigational Cancer Drug Can Boost Regeneration of Damaged Nerves After Spinal Cord Injury
- Labiotech.euResearch identifies new treatment target for CNS injury and neurological disease